Clinical impact of inflammatory and nutrition index based on metabolic tumor activity in non‑small cell lung cancer treated with immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical impact of inflammatory and nutrition index based on metabolic tumor activity in non‑small cell lung cancer treated with immunotherapy

Published:2024-01-19 Issue:3 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Ito Koki¹,Hashimoto Kousuke¹,Kaira Kyoichi¹,Yamaguchi Ou¹,Mouri Atsuto¹,Shiono Ayako¹,Miura Yu¹,Kobayashi Kunihiko¹,Imai Hisao¹,Kuji Ichiei²,Kagamu Hiroshi¹

Affiliation:

1. Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Hidaka, Saitama 350‑1298, Japan

2. Department of Nuclear Medicine, International Medical Center, Saitama Medical University, Hidaka, Saitama 350‑1298, Japan

Publisher

Spandidos Publications

Reference35 articles.

1. EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer;Hastings;Ann Oncol,2019

2. First-line nivolumab plus ipilimumab in advanced non-small-cell lung cancer (CheckMate 568): Outcome by programmed death ligand 1 and tumor mutational burden as biomarkers;Ready;J Clin Oncol,2019

3. CD4+ T-cell immunity in the peripheral blood correlates with response to anti-PD-1 therapy;Kagamu;Cancer Immunol Res,2020

4. Prognostic significance of tumor infiltrating lymphocytes on first–line pembrolizumab efficacy in advanced non–small cell lung cancer;Kaira;Discov Oncol,2023

5. Tumor metabolic volume by 18F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1≧50;Yamaguchi;Sci Rep,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP